Monteleone et al. [289] reported as the pharmacological activation of AhR decreases the proinflammatory cytokine IFNγ and increases the production of IL-22 in lamina propria mononuclear cells from IBD patients. The gene discussed is IL22; the disease is inflammatory bowel disease.